Media

Intra-articular Treatment of Osteoarthritis with Diclofenac-Conjugated Polymer Reduces Inflammation and Pain

27-11-2019

Media Publications
Authors:

ACS Appl. Bio Mater (2019), 2, 2822−2832. DOI: 10.1021/acsabm.9b00232.  Published: 24 May 2019.

Download

Our Unique Technology

30-10-2019

Media Videos

An update on PolyActiva’s drug delivery platform, showcasing its Latanoprost FA SR Ocular Implant for the treatment of glaucoma.

Download

PolyActiva completes recruitment in key Phase I glaucoma implant safety study. Six-month treatment period demonstrated.

24-07-2019

Media Announcements

July 23, Chicago – PolyActiva Pty Ltd, a clinical-stage biotechnology company and leader in ocular drug delivery, has completed patient enrolment for its Phase I clinical trial to study safety and tolerability of its biodegradable, slow-release ocular implant for the treatment of glaucoma…

Download

PolyActiva commences its first Phase I clinical trial

31-08-2018

Media Announcements

PolyActiva Pty Ltd, a clinical-stage Australian biotechnology company, has recently recruited first patients into its Phase I clinical study designed to show its glaucoma implant is safe and well tolerated…

Download

Precise Control of Drug Loading and Release of an NSAID-polymer Conjugate for Long Term Osteoarthritis Intra-articular Drug Delvery

24-07-2017

Media Publications
Authors:

J. Mater.Chem B (2017), 5, 6221-6226. DOI: 10.1039/C7TB01518F, Published: 24 July 2017. 

Download